Is Mark DeRosa a fit for the Mets at first base?

Leave a comment

In his weekly column for the Boston
Globe, Nick Cafardo reports that Mark DeRosa’s asking price — once in
the $10 million range —
has come down recently.
He follows that up with a pretty innocent statement that the Mets could
“pull the trigger and use him at first base.” This seems like pure
speculation on Cafardo’s part, not backed by any real information or
sources, but now that this specific passage has been noted in a few
places, the possibility should at least be addressed.




The Mets don’t make any sense for
DeRosa. In fact, any first baseman who craves regular playing time and
a multi-year contract doesn’t. The Mets seem committed to using Daniel
Murphy as part of a platoon at first base, ideally with a right-handed
hitting compliment, but possibly with Carlos Delgado on an
incentive-laden contract.

The Mets surely hope that whoever fills first
base in 2010 is a mere stopgap until Ike Davis arrives, possibly as
soon as next season. Davis, who turns 23 in March, batted
.298/.381/.524 with 20 home runs and 71 RBI in his first full
professional season in 2009, and was recently named the No. 4 prospect in the organization by Baseball America.



On top of all that, the 34-year-old DeRosa has only played 23 games at first base during his major league career. DeRosa is average or better in the
outfield, according to defensive metrics, but should the Mets sign
Jason Bay, as many expect they will, he wouldn’t find any regular
playing time there, either. DeRosa’s versatility is a huge reason why he is so coveted, but agent Keith Grunewald should be able to do better than the Mets, otherwise he has completely misread his client’s market.

Cam Bedrosian weighing surgery to remove a blood clot

ANAHEIM, CA - AUGUST 2: Pitcher Cam Bedrosian #68 of the Los Angeles Angels of Anaheim throws against the Oakland Athletics during the ninth inning at Angel Stadium of Anaheim August 2, 2016, in Anaheim, California. Angels defeated the Athletics, 5-4. (Photo by Kevork Djansezian/Getty Images)
Kevork Djansezian/Getty Images
1 Comment

Angels reliever Cam Bedrosian will take the next few days to decide whether or not to undergo surgery to remove a blood clot naer his right armpit, Mike DiGiovanna of the Los Angeles Times reports. The alternative is to treat the clot with blood-thinners and rest.

Bedrosian, 24, hasn’t pitched since blowing a save against the Athletics on August 3, shortly after he took over the closer’s role from the injured Huston Street. Bedrosian was diagnosed with flexor tendinitis in the middle finger of his throwing hand about a week later.

Overall, Bedrosian — the son of former major league closer Steve — has had an outstanding season, compiling a 1.12 ERA with a 51/14 K/BB ratio in 40 1/3 innings.

Shelby Miller will return to D-Backs’ rotation on Wednesday

PHOENIX, AZ - JULY 06:  Shelby Miller #26 of the Arizona Diamondbacks delivers a pitch during the first inning against the San Diego Padres at Chase Field on July 6, 2016 in Phoenix, Arizona.  (Photo by Jennifer Stewart/Getty Images)
Getty Images
Leave a comment

Nick Piecoro of the Arizona Republic reports that Shelby Miller will return to the Diamondbacks’ starting rotation on Wednesday to start against the Giants at AT&T Field.

Miller had an abysmal first half of the season, which included a stint on the disabled list with a finger injury caused by his follow-through. In 14 starts with the D-Backs this season, Miller put up a 7.14 ERA with a 50/34 K/BB ratio in 69 1/3 innings.

Miller was demoted to Triple-A Reno and made his first start shortly after the All-Star break. In eight starts in the minors, Miller compiled a much-improved 3.91 ERA with a 55/10 K/BB ratio in 50 2/3 innings.

The Diamondbacks acquired Miller along with minor leaguer Gabe Speier from the Braves this past winter in a heavily-criticized trade that sent Ender Inciarte, Aaron Blair, and 2015 No. 1 overall pick Dansby Swanson to Atlanta.